Detection, Quantification, and Characterization of Potentially Atherogenic Triglyceride-Rich Remnant Lipoproteins

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944

The Metabolic Basis of Inherited Disease.

(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_7 · Cited by 7,807

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

Plump, A. S., Smith, J. D., Hayek, T., Aalto-Setälä, K., Walsh, A., Verstuyft, J. G., Rubin, E. M., & Breslow, J. L. (1992) · Cell · doi:10.1016/0092-8674(92)90362-g · Cited by 2,263

Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein E

Zhang, S. H., Reddick, R. L., Piedrahita, J. A., & Maeda, N. (1992) · Science · doi:10.1126/science.1411543 · Cited by 2,237

Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies

Hokanson, J. E., & Austin, M. A. (1996) · Journal of Cardiovascular Risk · doi:10.1097/00043798-199604000-00014 · Cited by 1,706

ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.

Nakashima, Y., Plump, A. S., Raines, E. W., Breslow, J. L., & Ross, R. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.1.133 · Cited by 1,693

The Response-to-Retention Hypothesis of Early Atherogenesis

Williams, K. J., & Tabas, I. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.5.551 · Cited by 1,413

Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state

Patsch, J. R., Miesenböck, G., Hopferwieser, T., Mühlberger, V, Knapp, E., Dunn, J. K., Gotto, A. M., & Patsch, W. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.11.1336 · Cited by 1,122

The Role of Lipids and Lipoproteins in Atherosclerosis

Gofman, J. W., Lindgren, F. T., Elliott, H. A., Mantz, W., Hewitt, J. E., Strisower, B., Herring, V. V., & Lyon, T. P. (1950) · Science · doi:10.1126/science.111.2877.166 · Cited by 921

Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)

Watts, G. F., Lewis, B., Lewis, E. S., Coltart, D. J., Smith, L. D. R., Swan, A. V., Brunt, J. N. H., & Mann, J. I. (1992) · The Lancet · doi:10.1016/0140-6736(92)90863-x · Cited by 843

Pathophysiology of type 2 diabetes mellitus

Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176275 · Cited by 3,360

Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society

Ginsberg, H. N., Packard, C. J., Chapman, M. J., Borén, J., Aguilar-Salinas, C. A., Averna, M., Ference, B. A., Gaudet, D., Hegele, R. A., Kersten, S., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab551 · Cited by 979

Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation

Wang, L., Gill, R., Pedersen, T. L., Higgins, L. J., Newman, J. W., & Rutledge, J. C. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m700505-jlr200 · Cited by 303

Low-Density Lipoprotein, Non-High-Density Lipoprotein, and Apolipoprotein B as Targets of Lipid-Lowering Therapy

Grundy, S. M. (2002) · Circulation · doi:10.1161/01.cir.0000038419.53000.d6 · Cited by 309

The role of virgin olive oil components in the modulation of endothelial function

Perona, J. S., Cabello-Moruno, R., & Ruíz-Gutiérrez, V. (2005) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2005.11.007 · Cited by 282

Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications

Bays, H. E., Tighe, A. P., D, R. S. M., & Davidson, M. H. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.3.391 · Cited by 267

Apolipoproteins: metabolic role and clinical biochemistry applications

Dominiczak, M. H., & Caslake, M. J. (2011) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1258/acb.2011.011111 · Cited by 238

Elevated Remnant-Like Particle Cholesterol Concentration: A Characteristic Feature of the Atherogenic Lipoprotein Phenotype

Twickler, T. B., Dallinga-Thie, G. M., Cohn, J. S., & Chapman, M. J. (2004) · Circulation · doi:10.1161/01.cir.0000125278.58527.f3 · Cited by 201

New insights into the regulation of chylomicron production

Dash, S., Xiao, C., Morgantini, C., & Lewis, G. F. (2015) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071714-034338 · Cited by 194

Remnant Lipoproteins As Strong Key Particles to Atherogenesis

Fujioka, Y., & Ishikawa, Y. (2009) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.e598 · Cited by 146

Ezetimibe: cholesterol lowering and beyond

Bays, H. E., Neff, D., Tomassini, J. E., & Tershakovec, A. M. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.4.447 · Cited by 147

Postprandial Hyperlipidemia and Remnant Lipoproteins

Masuda, D., & Yamashita, S. (2017) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv16003 · Cited by 145

Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease

Hopkins, P. N., Wu, L., Hunt, S. C., & Brinton, E. A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.11.062 · Cited by 146

Triglyceride-Rich Lipoproteins Prime Aortic Endothelium for an Enhanced Inflammatory Response to Tumor Necrosis Factor-α

Ting, H. J., Stice, J. P., Schaff, U. Y., Hui, D. Y., Rutledge, J. C., Knowlton, A. A., Passerini, A. G., & Simon, S. I. (2007) · Circulation Research · doi:10.1161/01.res.0000258023.76515.a3 · Cited by 138

Lipolysis of triglyceride-rich lipoproteins, vascular inflammation, and atherosclerosis

Schwartz, E. A., & Reaven, P. D. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.09.021 · Cited by 130

Lipoprotein lipase: From gene to atherosclerosis

Li, Y., He, P.-P., Zhang, D.-W., Zheng, X.-L., Cayabyab, F. S., Yin, W.-D., & Tang, C.-K. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.10.016 · Cited by 109

Chylomicron remnants are increased in the postprandial state in CD36 deficiency

Masuda, D., Hirano, K., Oku, H., Sandoval, J. C., Kawase, R., Yuasa‐Kawase, M., Yamashita, Y., Takada, M., Tsubakio‐Yamamoto, K., Tochino, Y., et al. (2008) · Journal of Lipid Research · doi:10.1194/jlr.p700032-jlr200 · Cited by 124

Triglyceride-Rich Lipoprotein Remnants and Cardiovascular Disease

Duran, E. K., & Pradhan, A. D. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvaa296 · Cited by 108

Understanding Postprandial Inflammation and Its Relationship to Lifestyle Behaviour and Metabolic Diseases

Klop, B., Proctor, S. D., Mamo, J. C. L., Botham, K. M., & Cabezas, M. C. (2011) · International Journal of Vascular Medicine · doi:10.1155/2012/947417 · Cited by 96

Prognostic value of remnant-like lipoprotein particle levels in patients with coronary artery disease and type II diabetes mellitus

Fukushima, H., Sugiyama, S., Honda, O., Koide, S., Nakamura, S., Sakamoto, T., Yoshimura, M., Ogawa, H., Fujioka, D., & Kugiyama, K. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.09.074 · Cited by 91

Recent insights into factors affecting remnant lipoprotein uptake

Williams, K. J., & Chen, K. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328338cabc · Cited by 91

Are Remnant-Like Particles Independent Predictors of Coronary Heart Disease Incidence?

Imke, C., Rodríguez, B. L., Grove, J., McNamara, J. R., Waslien, C., Katz, A. R., Willcox, B. J., Yano, K., & Curb, J. D. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000173310.85845.7b · Cited by 89

The contribution of ApoB and ApoA1 measurements to cardiovascular risk assessment

Andrikoula, M., & McDowell, I. F. W. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00714.x · Cited by 88

Hyperlipoproteinemia Type 3: The Forgotten Phenotype

Hopkins, P. N., Brinton, E. A., & Nanjee, M. N. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0440-2 · Cited by 91

Impaired postprandial apolipoprotein-B48 metabolism in the obese, insulin-resistant JCR:LA-cp rat: Increased atherogenicity for the metabolic syndrome

Vine, D. F., Takechi, R., Russell, J. C., & Proctor, S. D. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.03.013 · Cited by 88

Effect of Statin Therapy on Remnant Lipoprotein Cholesterol Levels in Patients With Combined Hyperlipidemia

Stein, D. T., Devaraj, S., Balis, D. S., ADAMS-HUET, B. A., & Jialal, I. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq1201.100259 · Cited by 87

Regulation of chylomicron production in humans

Xiao, C., & Lewis, G. F. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.09.019 · Cited by 80

Ezetimibe improves postprandial hyperlipemia and its induced endothelial dysfunction

Yunoki, K., Nakamura, K., Miyoshi, T., Enko, K., Kohno, K., Morita, H., KUSANO, K. F., & Ito, H. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.04.019 · Cited by 74

Effect of apolipoprotein E, peroxisome proliferator-activated receptor alpha and lipoprotein lipase gene mutations on the ability of fenofibrate to improve lipid profiles and reach clinical guideline targets among hypertriglyceridemic patients.

Brisson, D., Ledoux, K., Bossé, Y., St‐Pierre, J., Julien, P., Perron, P., Hudson, T. J., Vohl, M., & Gaudet, D. (2002) · Pharmacogenetics · doi:10.1097/00008571-200206000-00007 · Cited by 74

Abnormalities in apo B-containing lipoproteins in diabetes and atherosclerosis

TOMKIN, G. H., & Owens, D. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.179 · Cited by 71

Remnant lipoproteins and atherosclerosis

Twickler, T., Dallinga-Thie, G., Chapman, M. J., & Cohn, J. (2005) · Current Atherosclerosis Reports · doi:10.1007/s11883-005-0037-x · Cited by 74

Effect of statin versus fibrate on postprandial endothelial dysfunction: role of remnant-like particles

Wilmink, H. W. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00227-9 · Cited by 68

Premature myocardial infarction is strongly associated with increased levels of remnant cholesterol

Goliasch, G., Wiesbauer, F., Blessberger, H., Demyanets, S., Wojta, J., Huber, K., Maurer, G., Schillinger, M., & Speidl, W. S. (2015) · Journal of clinical lipidology · doi:10.1016/j.jacl.2015.08.009 · Cited by 67

Remnant Lipoproteins from Patients with Sudden Cardiac Death Enhance Coronary Vasospastic Activity Through Upregulation of Rho-Kinase

Oi, K., Shimokawa, H., Hiroki, J., Uwatoku, T., Abe, K., Matsumoto, Y., Nakajima, Y., Nakajima, K., Takeichi, S., & Takeshita, A. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000126678.93747.80 · Cited by 65

Spotlight on HDL-raising therapies: insights from the torcetrapib trials

Kontush, A., Guérin, M., & Chapman, M. J. (2008) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1191 · Cited by 59

Accelerated atherosclerosis, dyslipidemia, and oxidative stress in end-stage renal disease

Mathur, S., Devaraj, S., & Jialal, I. (2002) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200203000-00003 · Cited by 59

Atherogenic postprandial remnant lipoproteins; VLDL remnants as a causal factor in atherosclerosis

Nakajima, K., & Tanaka, A. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.12.039 · Cited by 54

The Effects of Medications Used for the Management of Diabetes and Obesity on Postprandial Lipid Metabolism

Eleftheriadou, I., Grigoropoulou, P., Katsilambros, N., & Tentolouris, N. (2008) · Current Diabetes Reviews · doi:10.2174/157339908786241133 · Cited by 55

Development of a Homogeneous Assay to Measure Remnant Lipoprotein Cholesterol

Miyauchi, K., Kayahara, N., Ishigami, M., Kuwata, H., Mori, H., Sugiuchi, H., Irie, T., Tanaka, A., Yamashita, S., & Yamamura, T. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.092296 · Cited by 56

Postprandial Remnant-like Lipoproteins in Hypertriglyceridemia1

Ooi, T. C., Cousins, M., Ooi, D. S., Steiner, G. A., Uffelman, K. D., Nakajima, K., & Simo, I. E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7627 · Cited by 55

Postprandial Lipemia and Remnant Lipoproteins

Cohn, J. S. (2006) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2006.07.003 · Cited by 55

Remnants, LDL, and the Quantification of Lipoprotein-Associated Risk in Atherosclerotic Cardiovascular Disease

Packard, C. J. (2022) · Current Atherosclerosis Reports · doi:10.1007/s11883-022-00994-z · Cited by 54

Update on the laboratory investigation of dyslipidemias

Ramasamy, I. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.01.015 · Cited by 50

Remnant lipoproteins and atherogenesis.

Kawakami, A., Yoshida, M., Tanaka, A., Nakajima, K., Yasukochi, Y., Shimokado, K., & Numano, F. (2001) · Annals of the New York Academy of Sciences · doi:10.5551/jat.12.73 · Cited by 28

Atherosclerosis is accelerated in patients with long-term well-controlled Systemic Lupus Erythematosus (SLE)

Sato, H., Miida, T., Wada, Y., Maruyama, M., Murakami, S., Hasegawa, H., Kuroda, T., Narita, I., Nakano, M., & Gejyo, F. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.04.023 · Cited by 46

ApoE ε2/ε3/ε4 polymorphism, ApoC-III/ApoE ratio and metabolic syndrome

Olivieri, O., Martinelli, N., Bassi, A., Trabetti, E., Girelli, D., Pizzolo, F., Friso, S., Pignatti, P. F., & Corrocher, R. (2007) · Clinical and Experimental Medicine · doi:10.1007/s10238-007-0142-y · Cited by 46

VLDL-induced triglyceride accumulation in human macrophages is mediated by modulation of LPL lipolytic activity in the absence of change in LPL mass

Milosavljevic, D., Kontush, A., Griglio, S., Naour, G. L., Thillet, J., & Chapman, M. J. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00355-4 · Cited by 45

Oral supplementation with l-aspartate and l-glutamate inhibits atherogenesis and fatty liver disease in cholesterol-fed rabbit

Yanni, A. E., Agrogiannis, G. D., Nomikos, T., Fragopoulou, E., Pantopoulou, A., Antonopoulou, S., & Perrea, D. N. (2009) · Amino Acids · doi:10.1007/s00726-009-0340-x · Cited by 44

Conventional and Novel Lipid Measures and Risk of Peripheral Artery Disease

Kou, M., Ding, N., Ballew, S. H., Salameh, M., Martin, S. S., Selvin, E., HEISS, G. M., Ballantyne, C. M., Matsushita, K., & Hoogeveen, R. C. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.315828 · Cited by 44

Component Analysis of HPLC Profiles of Unique Lipoprotein Subclass Cholesterols for Detection of Coronary Artery Disease

Okazaki, M., Usui, S., Fukui, A., Kubota, I., & Tomoike, H. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2006.070094 · Cited by 44

Remnant-like particle cholesterol and triglyceride levels of hypertriglyceridemic patients in the fed and fasted state.

Marcoux, C., Hopkins, P. N., Wang, T., Leary, E. T., Nakajima, K., Davignon, J., & Cohn, J. S. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33455-6 · Cited by 43

Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins

Marcoux, C., Tremblay, M., Fredenrich, A., Davignon, J., & Cohn, J. S. (2001) · Metabolism · doi:10.1053/meta.2001.19452 · Cited by 41

The Role of Apolipoproteins in the Commonest Cancers: A Review

Darwish, N. M., Al‐Hail, M., Mohamed, Y. H., Al-Saady, R., Mohsen, S., Zar, A., Al-Mansoori, L., & Pedersen, S. (2023) · Cancers · doi:10.3390/cancers15235565 · Cited by 40

Cilostazol and atherogenic dyslipidemia: a clinically relevant effect?

Rizzo, M., Corrado, E., Patti, A. M., Rini, G. B., & Mikhailidis, D. P. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.557359 · Cited by 41

Chylomicron and apoB48 metabolism in the JCR:LA corpulent rat, a model for the metabolic syndrome

Mangat, R., Su, J. W., Scott, P. G., Russell, J. C., Vine, D. F., & Proctor, S. D. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350477 · Cited by 39

High Levels of Remnant Lipoprotein Cholesterol Is a Risk Factor for Large Artery Atherosclerotic Stroke

Kim, J.-Y., Park, J.-H., Jeong, S.-W., Schellingerhout, D., Park, J., Lee, D.-K., Choi, W. J., Chae, S., & Kim, D.-E. (2011) · Journal of Clinical Neurology · doi:10.3988/jcn.2011.7.4.203 · Cited by 35

Lipoprotein Abnormalities in Chronic Kidney Disease and Renal Transplantation

Barbagallo, C. M., Cefalu, A. B., Giammanco, A., Noto, D., Caldarella, R., Ciaccio, M., Averna, M. R., & Nardi, E. (2021) · Life · doi:10.3390/life11040315 · Cited by 47

Postprandial lipemia is modified by the presence of the polymorphism present in the exon 1 variant at the SR-BI gene locus

Pérez‐Martínez, P., López‐Miranda, J., Ordovás, J. M., Bellido, C., Marı́n, C., Gomez, P., Paniagua, J. A., Moreno, J., Fuentes, F. J., & Pérez‐Jiménez, F. (2004) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0320237 · Cited by 40

Plant Stanol Supplementation Decreases Serum Triacylglycerols in Subjects with Overt Hypertriglyceridemia

Theuwissen, E., Plat, J., Kallen, C., van Greevenbroek, M. M. J., & Mensink, R. P. (2009) · Lipids · doi:10.1007/s11745-009-3367-6 · Cited by 39

Remnant-like Particle-Cholesterol Concentrations in Patients with Type 2 Diabetes Mellitus and End-Stage Renal Disease

Hirany, S. V., O’Byrne, D., Devaraj, S., & Jialal, I. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.5.667 · Cited by 39

Obesity, Glucose Intolerance and Diabetes and Their Links to Cardiovascular Disease. Implications for Laboratory Medicine

Dominiczak, M. H. (2003) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2003.194 · Cited by 39

Remnant lipoproteins and atherosclerotic cardiovascular disease

Tada, H., Nohara, A., Inazu, A., Mabuchi, H., & Kawashiri, M.-A. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.12.014 · Cited by 37

Atherogenic Lipoproteins in Subclinical Hypothyroidism and Their Relationship with Hepatic Lipase Activity: Response to Replacement Treatment with Levothyroxine

Brenta, G., Berg, G. A., Miksztowicz, V., Lopez, G. I., Lucero, D., Faingold, C., Murakami, M., Machima, T., Nakajima, K., & Schreier, L. E. (2016) · Thyroid · doi:10.1089/thy.2015.0140 · Cited by 36

Polyhedral 3D structure of human plasma very low density lipoproteins by individual particle cryo-electron tomography1

Yu, Y., Kuang, Y., Lei, D., Zhai, X., Zhang, M., Krauss, R. M., & Ren, G. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m070375 · Cited by 38

Methods to assess impaired post‐prandial metabolism and the impact for early detection of cardiovascular disease risk

Su, J. W., Nzekwu, M. M. U., Cabezas, M. C., Redgrave, T. G., & Proctor, S. D. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02179.x · Cited by 34

Regulation of postprandial lipemia: an update on current trends.

Paglialunga, S., & Cianflone, K. (2007) · Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme · doi:10.1139/h06-100 · Cited by 33

Prognostic utility of triglyceride-rich lipoprotein-related markers in patients with coronary artery disease

Cao, Y., Zhang, H., Jin, J., Liu, H., Zhang, Y., Xu, R., Gao, Y., Guo, Y., Zhu, C., Hua, Q., et al. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra120000746 · Cited by 31

Detection of triglyceride using an iridium nano-particle catalyst based amperometric biosensor

Liao, W.-Y., Liu, C.-C., & Chou, T. (2008) · The Analyst · doi:10.1039/b801703d · Cited by 31

Triglyceride-rich lipoproteins, remnants and atherosclerotic cardiovascular disease: What we know and what we need to know

Chapman, M. J., Packard, C. J., Björnson, E., Ginsberg, H. N., & Borén, J. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.120529 · Cited by 36

Is Lipid Control Necessary in Hemodialysis Patients?

Cheung, A. K. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04780709 · Cited by 30

Effect of remnant-like particle on shear-induced platelet activation and its inhibition by antiplatelet agents

Yamazaki, M., Uchiyama, S., Xiong, Y., Nakano, T., Nakamura, T., & Iwata, M. (2004) · Thrombosis Research · doi:10.1016/j.thromres.2004.08.029 · Cited by 30

Altered composition of triglyceride-rich lipoproteins and coronary artery disease in a large case–control study

Hopkins, P. N., Nanjee, M. N., Wu, L. L., McGinty, M. G., Brinton, E. A., Hunt, S. C., & Anderson, J. L. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.05.016 · Cited by 29

Storage of human plasma samples leads to alterations in the lipoprotein distribution of apoC-III and apoE

Cohn, J. S., Rodriguez, C., Jacques, H., Tremblay, M., & Davignon, J. (2004) · Journal of Lipid Research · doi:10.1194/jlr.d300041-jlr200 · Cited by 31

Pathophysiologic and Treatment Strategies for Cardiovascular Disease in End-Stage Renal Disease and Kidney Transplantations

Ghanta, M., Kozicky, M., & Jim, B. (2014) · Cardiology in Review · doi:10.1097/crd.0000000000000044 · Cited by 28

Construction of an amperometric TG biosensor based on AuPPy nanocomposite and poly (indole-5-carboxylic acid) modified Au electrode

Narang, J., Chauhan, N., Rani, P., & Pundir, C. S. (2012) · Bioprocess and Biosystems Engineering · doi:10.1007/s00449-012-0799-9 · Cited by 28

Post-prandial remnant lipids impair arterial compliance.

Nestel, P., Shige, H., Pomeroy, S., Cehun, M., & Chin-dusting, J. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01251-7 · Cited by 32

Therapeutic Effects of Fibrates in Postprandial Lipemia

Kolovou, G. D., Kostakou, P. M., Anagnostopoulou, K. K., & Cokkinos, D. V. (2008) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200808040-00004 · Cited by 27

Effect of fibrates on postprandial remnant-like particles in patients with combined hyperlipidemia

Ooi, T. C. (2003) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.10.016 · Cited by 27

Adult-onset growth hormone deficiency: Relation of postprandial dyslipidemia to premature atherosclerosis.

Twickler, T., Cramer, M., Dallinga-Thie, G., Chapman, M., Erkelens, D., & Koppeschaar, H. (2003) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jc.2003-030278 · Cited by 30

Effects of Atorvastatin Therapy on the Low-Density Lipoprotein Subfraction, Remnant-Like Particles Cholesterol, and Oxidized Low-Density Lipoprotein Within 2 Weeks in Hypercholesterolemic Patients

Sakabe, K., Fukuda, N., Wakayama, K., Nada, T., Shinohara, H., & Tamura, Y. (2003) · Circulation Journal · doi:10.1253/circj.67.866 · Cited by 25

Apolipoprotein B-48: comparison of fasting concentrations measured in normolipidaemic individuals using SDS–PAGE, immunoblotting and ELISA

Jackson, K. G., & Williams, C. M. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.02.003 · Cited by 24

Acute Coffee Ingestion Does Not Affect LDL Cholesterol Level

Cheung, R. J., Gupta, E. K., & Ito, M. K. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1g005 · Cited by 24

Remnant Lipoproteins: Measurement and Clinical Significance

Jialal, I., & Devaraj, S. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.2.217 · Cited by 24

Remnant cholesterol predicts periprocedural myocardial injury following percutaneous coronary intervention in poorly-controlled type 2 diabetes.

Zeng, R.-X., Li, S., Zhang, M.-Z., Li, X.-L., Zhu, C.-G., Guo, Y.-L., Zhang, Y., & Li, J.-J. (2017) · Journal of Cardiology · doi:10.1016/j.jjcc.2016.12.010 · Cited by 20

Triglycerides and remnant particles as risk factors for coronary artery disease

Nakamura, T., & Kugiyama, K. (2006) · Current Atherosclerosis Reports · doi:10.1007/s11883-006-0047-3 · Cited by 22

Lab-on-a-chip for analysis of triglycerides based on a replaceable enzyme carrier using magnetic beads

Chen, S., Yu, X., Xu, J., & Chen, H. (2010) · The Analyst · doi:10.1039/c0an00231c · Cited by 21

Development of a Novel Homogeneous Assay for Remnant Lipoprotein Particle Cholesterol

Hirao, Y., Nakajima, K., Machida, T., Murakami, M., & Ito, Y. (2018) · The Journal of Applied Laboratory Medicine · doi:10.1373/jalm.2017.024919 · Cited by 21

Vascular Disease Risk in Patients With Hypertriglyceridemia: Endothelial Progenitor Cells, Oxidative Stress, Accelerated Senescence, and Impaired Vascular Repair

Thorin, É. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2011.03.014 · Cited by 21

New Insights Into How the Intestine Can Regulate Lipid Homeostasis and Impact Vascular Disease: Frontiers for New Pharmaceutical Therapies to Lower Cardiovascular Disease Risk

Warnakula, S., Hsieh, J., Adeli, K., Hussain, M. M., Tso, P., & Proctor, S. D. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2010.12.020 · Cited by 19

Accumulation of apoE-enriched triglyceride-rich lipoproteins in patients with coronary artery disease

Barbagallo, C. M., Rizzo, M., Noto, D., Frasheri, A., Pernice, V., Rubino, A., Pieri, D., Pinto, V., Cefalu, A. B., Giordano, C. S. D. S., et al. (2006) · Metabolism · doi:10.1016/j.metabol.2006.01.005 · Cited by 19

Risk Factors for Coronary Disease: the Time for a Paradigm Shift?

Dominiczak, M. H. (2001) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2001.147 · Cited by 19

Novel unbiased equations to calculate triglyceride-rich lipoprotein cholesterol from routine non-fasting lipids

Hermans, M. P., Ahn, S. A., & Rousseau, M. F. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-56 · Cited by 18

Time course differences for statin-induced pleiotropic effects in hypercholesterolemic patients

Sakabe, K., Fukuda, N., Wakayama, K., Nada, T., Shinohara, H., & Tamura, Y. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.08.001 · Cited by 18

Triglyceride content in remnant lipoproteins is significantly increased after food intake and is associated with plasma lipoprotein lipase

Nakajima, K., Tokita, Y., Sakamaki, K., Shimomura, Y., Kobayashi, J., Kamachi, K., Tanaka, A., Stanhope, K. L., Havel, P. J., Wang, T., et al. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.12.011 · Cited by 17

Non-high-density lipoprotein cholesterol is a practical predictor of long-term cardiac death after coronary artery bypass grafting

Fukushima, Y., Ohmura, H., Mokuno, H., Kajimoto, K., Kasai, T., Hirayama, S., Miyauchi, K., Miida, T., Amano, A., & Daida, H. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.12.012 · Cited by 17

Influence of minor components of olive oils on the composition and size of TRLs and on macrophage receptors involved in foam cell formation

Cabello-Moruno, R., Perona, J. S., & Ruíz-Gutiérrez, V. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350470 · Cited by 17

Relation between charge-based apolipoprotein B-containing lipoprotein subfractions and remnant-like particle cholesterol levels

Zhang, B., Böttcher, A., Imaizumi, S., Noda, K., Schmitz, G., & Saku, K. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.03.004 · Cited by 16

Implications of decreased serum adiponectin for type IIb hyperlipidaemia and increased cholesterol levels of very-low-density lipoprotein in type II diabetic patients

Yoshida, H., Hirowatari, Y., Kurosawa, H., & Tada, N. (2005) · Clinical Science · doi:10.1042/cs20040353 · Cited by 16

Measurement of serum remnant-like lipoprotein particle-triglyceride (RLP-TG) and RLP-TG/total TG ratio using highly sensitive triglyceride assay reagent

Nakano, T., Tokita, Y., Nagamine, T., Tanaka, A., Okazaki, M., Yatsuzuka, S.-I., Tamei, N., Shimomura, Y., Ando, Y., Akamatsu, S., et al. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.09.040 · Cited by 14

Increase in aortic pulse wave velocity is associated with abnormal postprandial triglyceride response

Daskalova, D. C., Kolovou, G. D., Panagiotakos, D. B., Pilatis, N. D., & Cokkinos, D. V. (2005) · Clinical Cardiology · doi:10.1002/clc.4960281208 · Cited by 14

Triglyceride-Rich Lipoprotein Remnants and Cardiovascular Disease

Duran, E. K., & Pradhan, A. D. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvaa296 · Cited by 108

Remnant lipoproteins as therapeutic targets

Havel, R. J. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200012000-00008 · Cited by 107

Development of a novel homogeneous assay for remnant lipoproteins

Satoh, N., Ikaida, M., & Ito, Y. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.07.562

Triglyceride-rich lipoproteins, remnants and atherosclerotic cardiovascular disease: What we know and what we need to know

Chapman, M. J., Packard, C. J., Björnson, E., Ginsberg, H. N., & Borén, J. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.120529 · Cited by 36

Remnant Lipoproteins: Measurement and Clinical Significance

Jialal, I., & Devaraj, S. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.2.217 · Cited by 24